Fate Therapeutics
FATE
#9044
Rank
HK$0.96 B
Marketcap
HK$8.40
Share price
-1.82%
Change (1 day)
-54.62%
Change (1 year)

Fate Therapeutics (FATE) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$0.85 Billion

According to Fate Therapeutics 's latest financial reports the company's total liabilities are HK$0.85 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Fate Therapeutics - Total liabilities on balance sheet (from 2012 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$0.94 B-12.02%
2023-12-31HK$1.07 B-37.85%
2022-12-31HK$1.73 B-8.47%
2021-12-31HK$1.89 B2.53%
2020-12-31HK$1.84 B311.9%
2019-12-31HK$0.44 B8.83%
2018-12-31HK$0.41 B87.47%
2017-12-31HK$0.21 B29.33%
2016-12-31HK$0.16 B-26.79%
2015-12-31HK$0.23 B30.88%
2014-12-31HK$0.17 B382.56%
2013-12-31HK$36.71 M-92.59%
2012-12-31HK$0.49 B8.95%
2011-12-31HK$0.45 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Sarepta Therapeutics
SRPT
HK$16.91 B 1,882.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
HK$229.00 B 26,750.05%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
HK$21.78 B 2,454.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
HK$1.92 B 126.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$9.82 B 1,051.50%๐Ÿ‡บ๐Ÿ‡ธ USA